Palo Alto Medical Foundation-Gynecologic Oncology
Mountain View, California, United States
Medical clinic in Mountain View, California
701 E El Camino Real 3rd floor, Mountain View, CA 94040
About Palo Alto Medical Foundation-Gynecologic Oncology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
58
SWOG Cancer Research Network
25
Gynecologic Oncology Group
11
Alliance for Clinical Trials in Oncology
9
ECOG-ACRIN Cancer Research Group
6
GOG Foundation
6
NRG Oncology
3
Clinical Trials at Palo Alto Medical Foundation-Gynecologic Oncology
During the past decade, Palo Alto Medical Foundation-Gynecologic Oncology conducted 55 clinical trials. In the 10-year time frame, 55 clinical trials started and 62 clinical trials were completed, i.e. on
average, 112.7% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 42 clinical trials were completed. i.e. 525%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
2000-11-20
2016-07-16
Completed
31
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
2005-03-21
2022-02-22
Active, not recruiting
1,157
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors
2007-10-09
2015-06-25
Completed
64
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
2009-04-01
2013-02-01
Completed
452
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Palo Alto Medical Foundation-Gynecologic Oncology" #1 sponsor was "National Cancer Institute (NCI)" with 58 trials, followed by "SWOG Cancer Research Network" with 25 trials
sponsored, "Gynecologic Oncology Group" with 11 trials sponsored, "Alliance for Clinical Trials in Oncology" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group"
with 9 trials sponsored. Other sponsors include 4 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Palo Alto Medical Foundation-Gynecologic Oncology"
#1 collaborator was "National Cancer Institute (NCI)" with 60 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Agenus Inc." with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Palo Alto Medical Foundation-Gynecologic Oncology
According to Clinical.Site data, the most researched conditions in "Palo Alto Medical Foundation-Gynecologic Oncology" are
"Recurrent Ovarian Carcinoma" (11 trials), "Ovarian Seromucinous Carcinoma" (10 trials), "Recurrent Fallopian Tube Carcinoma" (9 trials), "Recurrent Primary Peritoneal Carcinoma" (9 trials) and "Recurrent Squamous Cell Lung Carcinoma" (9 trials). Many other conditions were trialed in "Palo Alto Medical Foundation-Gynecologic Oncology" in a lesser frequency.
Clinical Trials Intervention Types at Palo Alto Medical Foundation-Gynecologic Oncology
Most popular intervention types in "Palo Alto Medical Foundation-Gynecologic Oncology" are "Drug" (95 trials), "Other" (84 trials), "Biological" (51 trials), "Procedure" (32 trials) and "Radiation" (11 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (51 trials), "Quality-of-Life Assessment" (34 trials), "Paclitaxel" (27 trials), "Carboplatin" (22 trials) and "Computed Tomography" (17 trials). Other intervention names were less common.
Clinical Trials Genders at Palo Alto Medical Foundation-Gynecologic Oncology
The vast majority of trials in "Palo Alto Medical Foundation-Gynecologic Oncology" are
71 trials for "All" genders, 45 trials for "Female" genders and 2 trials for "Male" genders.
Clinical Trials Status at Palo Alto Medical Foundation-Gynecologic Oncology
Currently, there are NaN active trials in "Palo Alto Medical Foundation-Gynecologic Oncology".
undefined are not yet recruiting,
18 are recruiting,
63 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 26 completed trials in Palo Alto Medical Foundation-Gynecologic Oncology,
2 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Palo Alto Medical Foundation-Gynecologic Oncology, 2 "Phase 1"
clinical trials were conducted, 63 "Phase 2" clinical
trials and 62 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 4 trials that are defined as “Not Applicable".